Paradigm shifts in the medical and surgical management of rhinologic and allergic disease

It is such an honor to have the opportunity to return as Guest Editor for this edition of the American Journal of Rhinology and Allergy (AJRA), and I want to express my deepest gratitude to the Editors-in-Chief Rakesh Chandra, Raj Sindwani, and Anju Peters for their ongoing support and outstanding leadership. The AJRA is committed to presenting the latest and highest-quality clinical and translational research in the fields of rhinology, allergy, and skull base surgery. To that end, the November–December issue of the AJRA encompasses a broad spectrum of studies that offer new insights into the treatment of rhinologic and allergic disease. Chronic rhinosinusitis (CRS) has been characterized as a complex, inflammatory disorder with environmental, genetic, and local host factors, all contributing to its pathogenesis.1 However, the precise etiology of CRS is still unknown, and its optimal medical management remains controversial.2 In this issue of the AJRA, several studies aim to better our understanding of the mechanism of action of various medical therapies currently available for CRS. Because Th2 inflammation is known to play a role in certain CRS subtypes, Kennedy et al.3 investigated the impact of itraconazole on the differentiation of naive T cells into Th2 like cells in vitro. No effect on proliferation of unbiased T cells was evident with exposure to varying concentrations of itraconazole, which may explain, at least in part, why recent clinical trials have reported no clinical benefit with the use of antifungal therapy for CRS.4,5 In contrast, Shin et al.6 demonstrated that doxycycline successfully inhibited transforming growth factor 1–induced matrix metalloproteinase 2 expression, migration, and collagen contraction in nasal polyp-derived fibroblasts. Such findings underscore the effectiveness of doxycycline in reducing nasal polyp size in patients with CRS with nasal polyposis.7 Similarly, Ko et al.,8 showed that rapamycin inhibited transforming growth factor 1–induced myofibroblast differentiation, extracellular matrix production, and collagen contraction in nasal polyp-derived fibroblasts.8 Therefore, rapamycin may also become a part of our treatment armamentarium for CRS with nasal polyposis in the future. Alterations in the nascent sinus microbiome have recently been postulated to contribute to development of CRS.9 Consequently, current research has focused on the potential therapeutic effects of topical probiotics and/or antibiotics in restoring resident microbiota and modulating immune responses. In their in vitro study, Schwartz et al.10 found that gram-positive probiotics induced secretion of IL10 (which downregulates host inflammatory reactions) without damaging sinus epithelia. Likewise, in their clinical study, Lee and Davis11 assessed the efficacy of culture-directed topical antibiotic irrigations in the treatment of 58 patients with recalcitrant CRS. Improvement in LundKennedy endoscopic (p 0.05) and 20-item Sino-Nasal Outcome Test (p 0.16) scores were observed after 1 month of therapy, with 72% of the patients having negative posttreatment cultures.11 Although promising, randomized controlled trials are still necessary to adequately evaluate the role of topical probiotics and/or antibiotics in refractory CRS. In addition to CRS, this issue of the AJRA also includes studies that investigated the epidemiology and management of allergic disease. In a study of 17,500 subjects, Kim et al.12 determined that dry eye was significantly associated with allergic rhinitis and house-dust mite (Dermatophagoides farinae) sensitization in the Korean adult population. Following this tangent, Krajewska-Wojtys et al.13 discovered that local allergic rhinitis was underdiagnosed in young patients (12–18 years). In their series of 121 patients, 42.5% (73) with a previous diagnosis of nonallergic rhinitis were ultimately found to have positive reactions to grass (Phleum partense), Artemisia, and birch pollen based on skin-prick testing and serum specific IgE measurements. Furthermore, in the study by Kaur et al.,14 innate immune genes analysis of middle ear fluid samples revealed differential expression in children who were otitis prone versus non otitis prone children. With respect to treatment, Greiwe and Bernstein15 highlighted the advantages of combination therapy (i.e., intranasal corticosteroids–topical decongestants; azelastine–fluticasone) in management of complex rhinitis phenotypes. In addition, Arcigil et al.16 performed a literature review to explore new routes for administration of allergen immunotherapy. Intralymphatic (direct injection of allergens into lymph nodes), epicutaneous (placement of allergen patches on the skin), nasal (spraying of allergens into the nasal cavity), and oral cavity and/or mucosal delivery were all found to be safe and effective. Such novel application methods may represent new alternatives to subcutaneous and sublingual immunotherapy in the future. In another systematic review, Kennedy et al.17 discussed the pathogenesis, risks-benefits of aspirin desensitization, and the role of surgical intervention in aspirin-exacerbated respiratory disease. In terms of olfaction, Bilici et al.18 analyzed the effects of radioactive iodine treatment for papillary thyroid carcinoma on smell function. In a prospective clinical study of 62 patients, 46% experienced olfactory deterioration, with significant reduction in threshold, identification, and total smell scores (Connecticut Chemosensory Clinical Research Center olfactory test) up to 1 year after RAI. In addition, Kohli et al.19 examined the relationship between olfactory cleft opacification and olfaction in CRS patients with (12) and without (26) nasal polyposis. Volumetric analysis of the olfactory cleft using computed tomography imaging revealed significant correlations between the degree of opacification and olfactory threshold, discrimination, and identification scores (Sniffin’ Sticks test), findings that were more pronounced in the CRS with nasal polyposis group. Thus, olfactory cleft opacification on computed tomography imaging may be associated with clinical olfactory dysfunction. With continued advances in endoscopic techniques and instrumentation, new surgical approaches have been developed for the manJivianne T. Lee, M.D.